![John Amory](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Amory
Corporate Officer/Principal bei University of Washington
Profil
John A.
Amory is a Professor at the University of Washington, where he has been working since 2011.
He previously worked as a Director at Clarus Therapeutics, Inc. and as an Independent Director at Clarus Therapeutics Holdings, Inc. from 2021 to 2022.
Amory received a graduate degree from the University of Washington and a doctorate from the University of California, San Francisco.
Aktive Positionen von John Amory
Unternehmen | Position | Beginn |
---|---|---|
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | 01.07.2011 |
Ehemalige bekannte Positionen von John Amory
Unternehmen | Position | Ende |
---|---|---|
CLARUS THERAPEUTICS HOLDINGS, INC. | Direktor/Vorstandsmitglied | 31.10.2022 |
Clarus Therapeutics, Inc.
![]() Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Direktor/Vorstandsmitglied | - |
Ausbildung von John Amory
The University of California, San Francisco | Doctorate Degree |
University of Washington | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CLARUS THERAPEUTICS HOLDINGS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Clarus Therapeutics, Inc.
![]() Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Health Technology |